Literature DB >> 34133860

Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV.

Zian H Tseng1, Ellen Moffatt1, Anthony Kim1, Eric Vittinghoff1, Phil Ursell1, Andrew Connolly1, Jeffrey E Olgin1, Joseph K Wong1, Priscilla Y Hsue1.   

Abstract

BACKGROUND: The incidence of sudden cardiac death and sudden death caused by arrhythmia, as determined by autopsy, in persons with human immunodeficiency virus (HIV) infection has not been clearly established.
METHODS: Between February 1, 2011, and September 16, 2016, we prospectively identified all new deaths due to out-of-hospital cardiac arrest among persons 18 to 90 years of age, with or without known HIV infection, for comprehensive autopsy and toxicologic and histologic testing. We compared the rates of sudden cardiac death and sudden death caused by arrhythmia between groups.
RESULTS: Of 109 deaths from out-of-hospital cardiac arrest among 610 unexpected deaths in HIV-positive persons, 48 met World Health Organization criteria for presumed sudden cardiac death; of those, fewer than half (22) had an arrhythmic cause. A total of 505 presumed sudden cardiac deaths occurred between February 1, 2011, and March 1, 2014, in persons without known HIV infection. Observed incidence rates of presumed sudden cardiac death were 53.3 deaths per 100,000 person-years among persons with known HIV infection and 23.7 deaths per 100,000 person-years among persons without known HIV infection (incidence rate ratio, 2.25; 95% confidence interval [CI], 1.37 to 3.70). Observed incidence rates of sudden death caused by arrhythmia were 25.0 and 13.3 deaths per 100,000 person-years, respectively (incidence rate ratio, 1.87; 95% CI, 0.93 to 3.78). Among all presumed sudden cardiac deaths, death due to occult drug overdose was more common in persons with known HIV infection than in persons without known HIV infection (34% vs. 13%). Persons who were HIV-positive had higher histologic levels of interstitial myocardial fibrosis than persons without known HIV infection.
CONCLUSIONS: In this postmortem study, the rates of presumed sudden cardiac death and myocardial fibrosis were higher among HIV-positive persons than among those without known HIV infection. One third of apparent sudden cardiac deaths in HIV-positive persons were due to occult drug overdose. (Supported by the National Heart, Lung, and Blood Institute.).
Copyright © 2021 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2021        PMID: 34133860      PMCID: PMC8415173          DOI: 10.1056/NEJMoa1914279

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Postmortem toxicology.

Authors:  Gisela Skopp
Journal:  Forensic Sci Med Pathol       Date:  2010-03-04       Impact factor: 2.007

2.  Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Melissa Skanderson; Olga V Patterson; Scott L DuVall; Cynthia A Brandt; Kaku A So-Armah; Ramachandran S Vasan; Kris Ann Oursler; John Gottdiener; Stephen Gottlieb; David Leaf; Maria Rodriguez-Barradas; Russell P Tracy; Cynthia L Gibert; David Rimland; Roger J Bedimo; Sheldon T Brown; Matthew Bidwell Goetz; Alberta Warner; Kristina Crothers; Hilary A Tindle; Charles Alcorn; Justin M Bachmann; Amy C Justice; Adeel A Butt
Journal:  JAMA Cardiol       Date:  2017-05-01       Impact factor: 14.676

3.  Characteristics of sudden arrhythmic death in a diverse, urban community.

Authors:  Daniel A Steinhaus; Eric Vittinghoff; Ellen Moffatt; Amy P Hart; Philip Ursell; Zian H Tseng
Journal:  Am Heart J       Date:  2012-01       Impact factor: 4.749

4.  Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection.

Authors:  Jacob D Estes; Stephen Wietgrefe; Timothy Schacker; Peter Southern; Greg Beilman; Cavan Reilly; Jeffrey M Milush; Jeffrey D Lifson; Donald L Sodora; John V Carlis; Ashley T Haase
Journal:  J Infect Dis       Date:  2007-01-08       Impact factor: 5.226

5.  Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.

Authors:  Michelle DallaPiazza; Valerianna K Amorosa; Russell Localio; Jay R Kostman; Vincent Lo Re
Journal:  BMC Infect Dis       Date:  2010-05-13       Impact factor: 3.090

6.  Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.

Authors:  Felicia C Chow; Susan Regan; Steven Feske; James B Meigs; Steven K Grinspoon; Virginia A Triant
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

7.  Factors Predisposing to Survival After Resuscitation for Sudden Cardiac Arrest.

Authors:  Santo Ricceri; James W Salazar; Andrew A Vu; Eric Vittinghoff; Ellen Moffatt; Zian H Tseng
Journal:  J Am Coll Cardiol       Date:  2021-05-18       Impact factor: 24.094

8.  Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.

Authors:  Birgit Grund; Jason V Baker; Steven G Deeks; Julian Wolfson; Deborah Wentworth; Alessandro Cozzi-Lepri; Calvin J Cohen; Andrew Phillips; Jens D Lundgren; James D Neaton
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 9.  Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics.

Authors:  Martin Schulz; Stefanie Iwersen-Bergmann; Hilke Andresen; Achim Schmoldt
Journal:  Crit Care       Date:  2012-07-26       Impact factor: 9.097

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

View more
  7 in total

1.  CARDIOVASCULAR DISEASE IN HIV.

Authors:  Wendy S Post
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

2.  Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.

Authors:  Jonathan A Hudson; Edith D Majonga; Rashida A Ferrand; Pablo Perel; Shirjel R Alam; Anoop S V Shah
Journal:  JAMA       Date:  2022-09-13       Impact factor: 157.335

3.  A Chronic Condition Disguised as an Acute Event: the Case for Re-thinking Stimulant Overdose Death.

Authors:  Elise D Riley; Priscilla Y Hsue; Phillip O Coffin
Journal:  J Gen Intern Med       Date:  2022-06-17       Impact factor: 6.473

Review 4.  Addressing gaps in cardiovascular care for people with HIV: bridging scientific evidence and practice.

Authors:  Albert Liu; Matthew Feinstein
Journal:  Curr Opin HIV AIDS       Date:  2022-07-16       Impact factor: 4.061

5.  Evaluation of HIV-Related Cardiomyopathy in HIV-Positive Patients in Bushehr, Iran.

Authors:  Farhad Abbasi; Asha Alexander; Soolmaz Korooni Fardkhani; Dariush Iranpour; Kamran Mirzaei; Mohammadreza Kalantarhormozi; Mehrdad Haghighi; Marziyeh Bagheri
Journal:  Cureus       Date:  2022-08-16

6.  Circulating biomarker correlates of left atrial size and myocardial extracellular volume fraction among persons living with and without HIV.

Authors:  Wendy S Post; Katherine C Wu; Tess E Peterson; Christian Landon; Sabina A Haberlen; Fiona Bhondoekhan; Michael W Plankey; Frank J Palella; Damani A Piggott; Joseph B Margolick; Todd T Brown
Journal:  BMC Cardiovasc Disord       Date:  2022-09-03       Impact factor: 2.174

Review 7.  A Systematic Review Exploring the Effect of Human Immunodeficiency Virus on Cardiac Diseases.

Authors:  Mohammed J Alzubaidee; Raga Sruthi Dwarampudi; Sheena Mathew; Sumahitha Bichenapally; Vahe Khachatryan; Asmaa Muazzam; Chandani Hamal; Lakshmi Sai Deepak Reddy Velugoti; Godfrey Tabowei; Greeshma N Gaddipati; Maria Mukhtar; Safeera Khan
Journal:  Cureus       Date:  2022-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.